Patrick Heron, Board Member at Mirum Pharmaceuticals (NASDAQ:MIRM), reported a large insider buy on September 13, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Heron purchased 8,437 shares of Mirum Pharmaceuticals. The total transaction amounted to $256,791.
Mirum Pharmaceuticals shares are trading up 4.71% at $31.37 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make ...